AB SCIENCEAB SCIENCEAB SCIENCE

AB SCIENCE

No trades
Buy AB

AB fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

AB Science SA operates as a pharmaceutical company, which engages in the research, development, and marketing of synthetic therapeutic molecules for pathologies with high medical need, in diseases of the central nervous system, cancers, and inflammatory diseases. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

AB does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company